Recombinant erythropoietin as a neuroprotective treatment: in vitro and in vivo models.
about
Erythropoietin enhances hippocampal long-term potentiation and memoryErythropoietin improves operant conditioning and stability of cognitive performance in mice.Erythropoietin and hypothermia for hypoxic-ischemic encephalopathy.Epo and other hematopoietic factorsErythropoietin: an update on the therapeutic use in newborn infants and children.Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics.Erythropoietin and prematurity--where do we stand?Recent advances in neonatal pharmacotherapy.Use of agents stimulating erythropoiesis in digestive diseasesErythropoietin: emerging role of erythropoietin in neonatal neuroprotection.Erythropoietin: a novel therapy for hypoxic-ischaemic encephalopathy?The Neuroprotective Effect of Erythropoietin on Rotenone-Induced Neurotoxicity in SH-SY5Y Cells Through the Induction of Autophagy.Developing drug strategies for the neuroprotective treatment of acute ischemic stroke.Tract-based spatial statistics to assess the neuroprotective effect of early erythropoietin on white matter development in preterm infants.Neuroprotection in Pediatric Cardiac Surgery: What is On the Horizon?Efficacy of combination therapy with erythropoietin and methylprednisolone in clinical recovery of severe relapse in multiple sclerosis.Enteral administration of a simulated amniotic fluid to very low birth weight neonates.A comparison of high-dose recombinant erythropoietin treatment regimens in brain-injured neonatal rats.Pharmacokinetics of high-dose recombinant erythropoietin in plasma and brain of neonatal rats.Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis
P2860
Q21245342-772FD9DE-D30C-40AD-84AC-AEC9E4551063Q33479749-6ADD11DA-98BE-44B6-9E72-F38AA9EE1CCDQ35471285-D5158F10-84AE-4223-BAE9-FE09C6E606A7Q36059793-12D201E7-104B-461D-96F0-C5DD2AC8D5E4Q36150771-CFEEB00E-D365-4FB9-A65D-034B71CACF88Q36277628-81ACC545-6DFC-4116-A950-7F55F5A86DABQ36277959-AC6EEDE5-27EA-4112-96F6-404BB1C3EB57Q36434300-DA101FE8-E7E5-4347-BD2E-913D880799A7Q37368733-1ACD53C8-FAF1-46C4-9183-56F8A4CB8166Q38255341-F0019F86-5994-4F51-A970-C6F628D2CBD8Q38387887-DE153B4E-A478-4007-A8BF-ABD1F35D6E03Q38986871-65457A5E-82AD-4287-8F57-52AA1F576CACQ40429078-5AA6E812-36A7-444D-8D8C-3BAE44793062Q41656923-E1AF4281-384E-40EA-8D8C-2B1863121A75Q41869463-5CA64CE5-B492-402A-BDD1-49A6F491CD27Q45076147-A42CEADC-C16C-42D1-9C3C-EF6145A6DD64Q47385201-1D028537-EB73-497F-A87A-8BF1820659ADQ48161042-EEFF3FB1-110A-4D25-81B0-254EEC029865Q48208417-D8C44DE6-91B3-4807-AB3E-4C2472959FB4Q59264385-834DBDC9-A62B-4E5B-80E5-6AE36BAD56FB
P2860
Recombinant erythropoietin as a neuroprotective treatment: in vitro and in vivo models.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Recombinant erythropoietin as a neuroprotective treatment: in vitro and in vivo models.
@ast
Recombinant erythropoietin as a neuroprotective treatment: in vitro and in vivo models.
@en
Recombinant erythropoietin as a neuroprotective treatment: in vitro and in vivo models.
@nl
type
label
Recombinant erythropoietin as a neuroprotective treatment: in vitro and in vivo models.
@ast
Recombinant erythropoietin as a neuroprotective treatment: in vitro and in vivo models.
@en
Recombinant erythropoietin as a neuroprotective treatment: in vitro and in vivo models.
@nl
prefLabel
Recombinant erythropoietin as a neuroprotective treatment: in vitro and in vivo models.
@ast
Recombinant erythropoietin as a neuroprotective treatment: in vitro and in vivo models.
@en
Recombinant erythropoietin as a neuroprotective treatment: in vitro and in vivo models.
@nl
P1476
Recombinant erythropoietin as a neuroprotective treatment: in vitro and in vivo models.
@en
P2093
Sandra Juul
P304
P356
10.1016/J.CLP.2004.03.004
P577
2004-03-01T00:00:00Z